Acquisition of the Prata Laboratory by João Marques de Paulo.
1973
Acquisition of the Embu-Guaçu Unit (SP)
1980
Beginning of activities as the National Chemical Pharmaceutical Union.
1983
Start of activities at the graphic park in Embu-Guaçu (SP)
1998
Acquisition of the Searle line, with emphasis on the brand Vodol® Leader in the antimycotic market.
2000
Acquisition of the Agener veterinary laboratory
creation of the Animal Health Division.
Start of operations in Pouso Alegre (MG)
2003
Acquisition of the Genom Laboratory, creation of the Medical Prescription Division
2006
Start of activities at the Brasília (DF) plant
2007
Acquisition of the Bio Macro Laboratory
2010
Acquisition of the Tecnopec Laboratory. Agener enters the Animal Reproduction market.
2012
Acquisition of Bthek Biotecnologia – Brasília DF
Creation of the Bionovis company, focused on biotechnology, in partnership with 3 other large pharmaceutical companies
2015
Acquisition of the Novartis industrial complex in Taboão da Serra (SP), renamed Anovis
2017
Acquisition of the Zoetis industrial complex, in Guarulhos SP, renamed Inovat
2018
Inauguration of the logistics center and graphic park, in Pouso Alegre (MG)
2018
Acquisition of Elanco's biotechnology plant (Eli Lilly) in Georgia (United States), changing its name to Union Agener
2020
Acquisition of the Neocopan® brand
2021
Acquisition of the Laboratil manufacturing plant
2021
Launch of the Program with a goal of planting 1 million native trees within 5 years
2021
Acquisition of Slow-K brands. Xantinon®, market-leading Xantinon Complex® hepatoprotectors
2022
Acquisition of the industrial complex of Bayer – São Paulo SP Leadership in oral contraceptives in Latin America, highlighting the Ciclo 21® and Microvlar® brands